| REIPX | VIVIX | REIPX / VIVIX | |
| Total Expense Ratio | 0.56 | 0.03 | 1,867% |
| Annual Report Gross Expense Ratio | 0.56 | 0.03 | 1,867% |
| Fund Existence | 11 years | 28 years | - |
| Gain YTD | 17.823 | 15.125 | 118% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 5000000 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 18.1B | 254B | 7% |
| Annual Yield % from dividends | 1.39 | 1.86 | 75% |
| Returns for 1 year | 26.76 | 24.28 | 110% |
| Returns for 3 years | 39.17 | 50.26 | 78% |
| Returns for 5 years | 36.81 | 58.89 | 63% |
| Returns for 10 years | 74.97 | 154.95 | 48% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WPSIX | 50.46 | 0.91 | +1.84% |
| AB Concentrated Growth I | |||
| PABGX | 198.35 | 3.00 | +1.54% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| PCAQX | 92.01 | 0.39 | +0.43% |
| Principal Capital Appreciation R5 | |||
| SAMVX | 13.17 | 0.03 | +0.23% |
| Virtus Ceredex Mid-Cap Value Equity A | |||
| KMDVX | 34.84 | -0.01 | -0.03% |
| Keeley Gabelli Mid Cap Dividend A | |||